Hudson Bay Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Hudson Bay Capital Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-36,066	Closed	-$241K	–	964
2023 Q3	$241K	Buy	+36,066	New	+$300K	﹤0.01%	624

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Hudson Bay Capital Management's PNT Position: Q4 2023 in Review

Hudson Bay Capital Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 36,066 shares — an estimated $241K sold.

Hudson Bay Capital Management first reported a position in PNT in Q3 2023 and held it in 1 quarter. The position peaked at $241K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Hudson Bay Capital Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 36,066 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $241K.
Hudson Bay Capital Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2023 and held it in 1 quarter.
Hudson Bay Capital Management's POINT Biopharma Global Inc. Common Stock position peaked at $241K in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Hudson Bay Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.